{"id":5034,"date":"2024-11-19T00:25:26","date_gmt":"2024-11-19T00:25:26","guid":{"rendered":"https:\/\/aisperu.org.pe\/?page_id=5034"},"modified":"2025-12-10T03:20:32","modified_gmt":"2025-12-10T03:20:32","slug":"colombia-cronologia-del-proceso-de-licencia-obligatoria","status":"publish","type":"page","link":"https:\/\/aisperu.org.pe\/cms\/colombia-cronologia-del-proceso-de-licencia-obligatoria\/","title":{"rendered":"Colombia: Cronolog\u00eda del proceso de Licencia obligatoria"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"5034\" class=\"elementor elementor-5034\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7518e13 elementor-section-stretched elementor-section-full_width elementor-section-height-default elementor-section-height-default\" data-id=\"7518e13\" data-element_type=\"section\" data-settings=\"{&quot;stretch_section&quot;:&quot;section-stretched&quot;,&quot;animation_mobile&quot;:&quot;zoomIn&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-851c02b elementor-invisible\" data-id=\"851c02b\" data-element_type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;,&quot;animation&quot;:&quot;fadeIn&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-00ed5de elementor-widget elementor-widget-heading\" data-id=\"00ed5de\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Colombia: Cronolog\u00eda del proceso de Licencia obligatoria <\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f214f8e elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"f214f8e\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9d508ef elementor-section-stretched elementor-section-content-middle elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"9d508ef\" data-element_type=\"section\" data-settings=\"{&quot;stretch_section&quot;:&quot;section-stretched&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-064c951\" data-id=\"064c951\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-20e5c77 elementor-widget elementor-widget-text-editor\" data-id=\"20e5c77\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>La licencia obligatoria es una autorizaci\u00f3n otorgada por el gobierno para la explotaci\u00f3n de la materia patentada sin el consentimiento del titular, y tiene como finalidad garantizar determinados objetivos de pol\u00edtica p\u00fablica, como es el acceso a tratamientos. En Am\u00e9rica Latina, solo dos pa\u00edses han utilizado este mecanismo: Brasil (1 licencia) y Ecuador (11 licencias). En Colombia, desde diciembre de 2023 se ha inici\u00f3 el proceso de licencia para el medicamento dolutegravir, utilizado en la primera l\u00ednea de tratamiento del VIH, y representa un paso significativo para los pa\u00edses del sur global, demostrando la decisi\u00f3n pol\u00edtica y firme del gobierno de garantizar el acceso a tratamientos vitales para la poblaci\u00f3n, a pesar de la fuerte presi\u00f3n de la industria farmac\u00e9utica\u00a0por\u00a0impedirlo.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-0769021 elementor-section-stretched elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"0769021\" data-element_type=\"section\" data-settings=\"{&quot;stretch_section&quot;:&quot;section-stretched&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5768e33\" data-id=\"5768e33\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c8ee309 elementor-widget elementor-widget-shortcode\" data-id=\"c8ee309\" data-element_type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\">\t<div class=\"dtg-wrap\">\n\t\t<div class=\"dtg-header\">\n\t\t\t<h2 class=\"dtg-main-title\">Seguimiento: Licencia Obligatoria del DTG en Colombia<\/h2>\n\t\t\t<p class=\"dtg-subtitle\">L\u00ednea de tiempo del proceso de licencia obligatoria para el Dolutegravir (2023\u20132025)<\/p>\n\t\t<\/div>\n\n\t\t<div class=\"dtg-legend\">\n\t\t\t<span class=\"dtg-leg dtg-leg--hito\">Hito clave<\/span>\n\t\t\t<span class=\"dtg-leg dtg-leg--resolucion\">Resoluci\u00f3n<\/span>\n\t\t\t<span class=\"dtg-leg dtg-leg--juridico\">Acci\u00f3n jur\u00eddica<\/span>\n\t\t\t<span class=\"dtg-leg dtg-leg--circular\">Circular<\/span>\n\t\t\t<span class=\"dtg-leg dtg-leg--informe\">Informe \/ Acta<\/span>\n\t\t<\/div>\n\n\t\t<div class=\"dtg-scroll-wrap\">\n\t\t\t<div class=\"dtg-timeline\">\n\t\t\t\t<div class=\"dtg-line\"><\/div>\n\t\t\t\t\n\t\t<div class=\"dtg-item dtg-item--resolucion dtg-item--top\">\n\t\t\t<div class=\"dtg-card dtg-card--top\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--resolucion\">Resoluci\u00f3n<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/DE\/DIJ\/resolucion-881-de-2023.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Resoluci\u00f3n 881 de 2023 <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Se inicia el procedimiento administrativo para someter las patentes del Dolutegravir a licencia obligatoria.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--resolucion\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Jun 2023<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--resolucion dtg-item--bottom\">\n\t\t\t<div class=\"dtg-card dtg-card--bottom\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--resolucion\">Resoluci\u00f3n<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/Normatividad_Nuevo\/Resoluci%C3%B3n%20No.%201097%20de%202023.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Resoluci\u00f3n 1097 de 2023 <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Se delega al Director de Medicamentos como representante del MSPS ante el Comit\u00e9 Interinstitucional.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--resolucion\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Jul 2023<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--acta dtg-item--top\">\n\t\t\t<div class=\"dtg-card dtg-card--top\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--acta\">Acta<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/VS\/MET\/comite-interintitucional-declaratoria-publico-patente-obligatoria-dolutegravir-acta-01082023.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Comit\u00e9 T\u00e9cnico Interinstitucional <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Reuni\u00f3n del comit\u00e9 t\u00e9cnico de declaratoria de inter\u00e9s p\u00fablico para someter la patente a licencia obligatoria.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--acta\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Ago 2023<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--resolucion dtg-item--bottom\">\n\t\t\t<div class=\"dtg-card dtg-card--bottom\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--resolucion\">Resoluci\u00f3n<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/DE\/DIJ\/resolucion-1481-de-2023.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Resoluci\u00f3n 1481 de 2023 <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Se niega la solicitud de recusaci\u00f3n formulada por AFIDRO contra la Directora de Medicamentos y Tecnolog\u00edas en Salud.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--resolucion\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Sep 2023<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--hito dtg-item--top\">\n\t\t\t<div class=\"dtg-card dtg-card--top\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--hito\">Hito clave<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/Normatividad_Nuevo\/Resoluci%C3%B3n%20No%201579%20de%202023.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Resoluci\u00f3n No. 1579 de 2023 <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Se declara la existencia de razones de inter\u00e9s p\u00fablico para someter la patente del Dolutegravir a licencia obligatoria en modalidad de uso gubernamental.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--hito\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Oct 2023<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--informe dtg-item--bottom\">\n\t\t\t<div class=\"dtg-card dtg-card--bottom\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--informe\">Informe<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/VS\/MET\/comentarios-recursos-reposicion-unal-lizarazo.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Informe \u2014 Comentarios recurso de reposici\u00f3n <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Comentarios a recurso de reposici\u00f3n por Oscar Andr\u00e9s Lizarazo Cort\u00e9s.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--informe\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Oct 2023<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--resolucion dtg-item--top\">\n\t\t\t<div class=\"dtg-card dtg-card--top\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--resolucion\">Resoluci\u00f3n<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/Normatividad_Nuevo\/Resoluci%C3%B3n%20No%202022%20de%202023.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Resoluci\u00f3n No. 2022 de 2023 <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Se resuelve el recurso de reposici\u00f3n de ViiV Healthcare, Shionogi y GSK contra la Resoluci\u00f3n 1579.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--resolucion\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Dic 2023<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--resolucion dtg-item--bottom\">\n\t\t\t<div class=\"dtg-card dtg-card--bottom\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--resolucion\">Resoluci\u00f3n<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/Normatividad_Nuevo\/Resoluci%C3%B3n%20No%202023%20de%202023.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Resoluci\u00f3n No. 2023 de 2023 <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Se resuelve la solicitud de aclaraci\u00f3n de Reyes y Reyes Abogados contra la Resoluci\u00f3n 1579.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--resolucion\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Dic 2023<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--resolucion dtg-item--top\">\n\t\t\t<div class=\"dtg-card dtg-card--top\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--resolucion\">Resoluci\u00f3n<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/DE\/DIJ\/resolucion-2024-de-2023.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Resoluci\u00f3n No. 2024 de 2023 <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Se resuelve el recurso de reposici\u00f3n de AFIDRO contra la Resoluci\u00f3n 1579.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--resolucion\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Dic 2023<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--aviso dtg-item--bottom\">\n\t\t\t<div class=\"dtg-card dtg-card--bottom\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--aviso\">Aviso<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/sedeelectronica.sic.gov.co\/sites\/default\/files\/noticias\/2024\/Aviso_Tramite_de_Licencia-Formato_Accesible.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Aviso Solicitud Licencia Obligatoria <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Publicaci\u00f3n del tr\u00e1mite de solicitud de otorgamiento de licencia obligatoria en modalidad de uso gubernamental sobre la patente N\u00b0 1887.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--aviso\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Ene 2024<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--juridico dtg-item--top\">\n\t\t\t<div class=\"dtg-card dtg-card--top\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--juridico\">Acci\u00f3n jur\u00eddica<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/consultaprocesos.ramajudicial.gov.co\/Procesos\/NumeroRadicacion\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Demanda AFIDRO <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">AFIDRO solicita la nulidad de las resoluciones que declararon el inter\u00e9s p\u00fablico para otorgar la licencia obligatoria.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--juridico\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Feb 2024<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--hito dtg-item--bottom\">\n\t\t\t<div class=\"dtg-card dtg-card--bottom\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--hito\">Hito clave<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2024\/04\/NC_534_Licencia_obligatoria_aceptada.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Resoluci\u00f3n N\u00b0 20049 <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Se concede la licencia obligatoria por razones de inter\u00e9s p\u00fablico sobre la patente del Dolutegravir y se ordena su inscripci\u00f3n en el registro de propiedad industrial.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--hito\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Abr 2024<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--juridico dtg-item--top\">\n\t\t\t<div class=\"dtg-card dtg-card--top\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--juridico\">Acci\u00f3n jur\u00eddica<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.comunidadandina.org\/DocOficialesFiles\/Gacetas\/GACETA%205494.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Dictamen N\u00b0001 de 2024 \u2013 TJCA <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">El Tribunal de Justicia de la Comunidad Andina declara improcedente el reclamo de ViiV Healthcare, Shionogi y GSK contra Colombia.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--juridico\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Jun 2024<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--juridico dtg-item--bottom\">\n\t\t\t<div class=\"dtg-card dtg-card--bottom\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--juridico\">Acci\u00f3n jur\u00eddica<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/consultaprocesos.ramajudicial.gov.co\/Procesos\/NumeroRadicacion\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Demanda ViiV Healthcare <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">ViiV Healthcare solicita la nulidad de las resoluciones que otorgaron la licencia obligatoria.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--juridico\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Jul 2024<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--juridico dtg-item--top\">\n\t\t\t<div class=\"dtg-card dtg-card--top\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--juridico\">Acci\u00f3n jur\u00eddica<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.comunidadandina.org\/DocOficialesFiles\/Gacetas\/GACETA%205572.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Dictamen N\u00b0004 de 2024 \u2013 SGCAN <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">ViiV Healthcare presenta nuevo reclamo ante la Secretar\u00eda General de la Comunidad Andina por supuesto incumplimiento de la Decisi\u00f3n 486.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--juridico\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Oct 2024<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--resolucion dtg-item--bottom\">\n\t\t\t<div class=\"dtg-card dtg-card--bottom\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--resolucion\">Resoluci\u00f3n<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/consultorsalud.com\/wp-content\/uploads\/2024\/12\/Resolucion-2164-de-2024-.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Resoluci\u00f3n N\u00b0 2164 de 2024 <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Se establecen los criterios para la compra centralizada, distribuci\u00f3n y suministro de medicamentos antirretrovirales para VIH.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--resolucion\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Nov 2024<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--hito dtg-item--top\">\n\t\t\t<div class=\"dtg-card dtg-card--top\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--hito\">Hito clave<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/Paginas\/Colombia-avanza-en-el-acceso-a-tratamientos-esenciales-para-las-personas-con-VIH-garantizando-una-salud-digna.aspx\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Inicio distribuci\u00f3n DTG <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Colombia recibe m\u00e1s de 800,000 frascos del medicamento triconjugado DTG+TDF+3TC recomendado por la OMS.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--hito\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Feb 2025<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--circular dtg-item--bottom\">\n\t\t\t<div class=\"dtg-card dtg-card--bottom\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--circular\">Circular<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/Normatividad_Nuevo\/Circular%20Externa%20No%20006%20de%202025.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Circular Externa N\u00b0 006 de 2025 <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Minsalud establece directrices operativas para la prescripci\u00f3n y monitoreo de antirretrovirales a trav\u00e9s de MIPRES.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--circular\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Feb 2025<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--circular dtg-item--top\">\n\t\t\t<div class=\"dtg-card dtg-card--top\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--circular\">Circular<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/Normatividad_Nuevo\/Circular%20Externa%20No%20017%20de%202025.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Circular Externa N\u00b0 017 de 2025 <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Se implementa la ruta operativa para la distribuci\u00f3n, dispensaci\u00f3n y monitoreo del dolutegravir.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--circular\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">May 2025<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--informe dtg-item--bottom\">\n\t\t\t<div class=\"dtg-card dtg-card--bottom\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--informe\">Informe<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/CC\/Noticias\/2025\/Paginas\/minsalud-socializa-actualizacion-de-via-clinica-practica-fortaleciendo-respuesta-nacional-al-VIH.aspx\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Actualizaci\u00f3n V\u00eda Cl\u00ednica VIH <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Minsalud socializa la actualizaci\u00f3n de la V\u00eda Cl\u00ednica Pr\u00e1ctica para prevenci\u00f3n, diagn\u00f3stico, tratamiento y seguimiento de personas con VIH.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--informe\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">May 2025<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<div class=\"dtg-item dtg-item--informe dtg-item--top\">\n\t\t\t<div class=\"dtg-card dtg-card--top\">\n\t\t\t\t<span class=\"dtg-tag dtg-tag--informe\">Informe<\/span>\n\t\t\t\t<h4 class=\"dtg-card__title\"><a href=\"https:\/\/www.minsalud.gov.co\/sites\/rid\/Lists\/BibliotecaDigital\/RIDE\/VS\/MET\/informe-ejecucion-adquisicion-distribucion-medicamento-dlt-licencia-obligatoria-julio-2025.pdf\" target=\"_blank\" rel=\"noopener\" class=\"dtg-card__link\">Informe de ejecuci\u00f3n DTG <svg width=\"10\" height=\"10\" viewBox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2.5\"><path d=\"M18 13v6a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V8a2 2 0 0 1 2-2h6\"\/><polyline points=\"15 3 21 3 21 9\"\/><line x1=\"10\" y1=\"14\" x2=\"21\" y2=\"3\"\/><\/svg><\/a><\/h4>\n\t\t\t\t<p class=\"dtg-card__desc\">Se adquirieron 39 lotes; 13 (256,662 frascos) entregados a EPS. Se implement\u00f3 la plataforma ACMED para seguimiento de inventarios.<\/p>\n\t\t\t<\/div>\n\t\t\t<div class=\"dtg-dot-wrap\">\n\t\t\t\t<div class=\"dtg-dot dtg-dot--informe\"><\/div>\n\t\t\t\t<div class=\"dtg-date\">Jul 2025<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n\n\t<style>\n\t\/* \u2500\u2500 Wrapper principal \u2500\u2500 *\/\n\t.dtg-wrap {\n\t\twidth: 100%;\n\t\tfont-family: inherit;\n\t\tpadding: 20px 0 32px;\n\t\tbox-sizing: border-box;\n\t}\n\n\t\/* \u2500\u2500 Header \u2500\u2500 *\/\n\t.dtg-header { margin-bottom: 16px; }\n\t.dtg-main-title {\n\t\tfont-size: 1.3rem;\n\t\tfont-weight: 700;\n\t\tcolor: #1b5e20;\n\t\tmargin: 0 0 6px;\n\t}\n\t.dtg-subtitle {\n\t\tfont-size: 0.85rem;\n\t\tcolor: #666;\n\t\tmargin: 0 0 16px;\n\t}\n\n\t\/* \u2500\u2500 Leyenda \u2500\u2500 *\/\n\t.dtg-legend {\n\t\tdisplay: flex;\n\t\tflex-wrap: wrap;\n\t\tgap: 10px;\n\t\tmargin-bottom: 28px;\n\t}\n\t.dtg-leg {\n\t\tdisplay: inline-flex;\n\t\talign-items: center;\n\t\tgap: 6px;\n\t\tfont-size: 0.75rem;\n\t\tfont-weight: 600;\n\t\tpadding: 3px 10px;\n\t\tborder-radius: 20px;\n\t\tcolor: #fff;\n\t}\n\t.dtg-leg::before {\n\t\tcontent: '';\n\t\twidth: 8px;\n\t\theight: 8px;\n\t\tborder-radius: 50%;\n\t\tbackground: rgba(255,255,255,0.6);\n\t\tdisplay: inline-block;\n\t}\n\t.dtg-leg--hito       { background: #2e7d32; }\n\t.dtg-leg--resolucion { background: #1565c0; }\n\t.dtg-leg--juridico   { background: #b71c1c; }\n\t.dtg-leg--circular   { background: #e65100; }\n\t.dtg-leg--informe    { background: #6a1b9a; }\n\n\t\/* \u2500\u2500 Scroll container \u2500\u2500 *\/\n\t.dtg-scroll-wrap {\n\t\toverflow-x: auto;\n\t\toverflow-y: visible;\n\t\tpadding-bottom: 16px;\n\t\t-webkit-overflow-scrolling: touch;\n\t}\n\t.dtg-scroll-wrap::-webkit-scrollbar { height: 6px; }\n\t.dtg-scroll-wrap::-webkit-scrollbar-track { background: #f0f0f0; border-radius: 3px; }\n\t.dtg-scroll-wrap::-webkit-scrollbar-thumb { background: #a5d6a7; border-radius: 3px; }\n\n\t\/* \u2500\u2500 Timeline container \u2500\u2500 *\/\n\t.dtg-timeline {\n\t\tposition: relative;\n\t\tdisplay: flex;\n\t\talign-items: center;\n\t\tmin-width: max-content;\n\t\tpadding: 120px 40px 120px 40px;\n\t\tgap: 0;\n\t}\n\n\t\/* \u2500\u2500 L\u00ednea central \u2500\u2500 *\/\n\t.dtg-line {\n\t\tposition: absolute;\n\t\ttop: 50%;\n\t\tleft: 0;\n\t\tright: 0;\n\t\theight: 3px;\n\t\tbackground: linear-gradient(90deg, #a5d6a7, #2e7d32, #1565c0, #2e7d32, #a5d6a7);\n\t\ttransform: translateY(-50%);\n\t\tz-index: 1;\n\t}\n\n\t\/* \u2500\u2500 Item \u2500\u2500 *\/\n\t.dtg-item {\n\t\tposition: relative;\n\t\tdisplay: flex;\n\t\tflex-direction: column;\n\t\talign-items: center;\n\t\twidth: 200px;\n\t\tflex-shrink: 0;\n\t\tz-index: 2;\n\t}\n\n\t\/* \u2500\u2500 Dot + fecha \u2500\u2500 *\/\n\t.dtg-dot-wrap {\n\t\tdisplay: flex;\n\t\tflex-direction: column;\n\t\talign-items: center;\n\t\tgap: 6px;\n\t\tposition: relative;\n\t\tz-index: 3;\n\t}\n\t.dtg-dot {\n\t\twidth: 14px;\n\t\theight: 14px;\n\t\tborder-radius: 50%;\n\t\tborder: 3px solid #fff;\n\t\tbox-shadow: 0 0 0 2px currentColor;\n\t\tflex-shrink: 0;\n\t}\n\t.dtg-dot--hito       { background: #2e7d32; color: #2e7d32; width: 18px; height: 18px; }\n\t.dtg-dot--resolucion { background: #1565c0; color: #1565c0; }\n\t.dtg-dot--juridico   { background: #b71c1c; color: #b71c1c; }\n\t.dtg-dot--acta       { background: #6a1b9a; color: #6a1b9a; }\n\t.dtg-dot--aviso      { background: #e65100; color: #e65100; }\n\t.dtg-dot--circular   { background: #e65100; color: #e65100; }\n\t.dtg-dot--informe    { background: #6a1b9a; color: #6a1b9a; }\n\n\t.dtg-date {\n\t\tfont-size: 0.72rem;\n\t\tfont-weight: 700;\n\t\tcolor: #333;\n\t\twhite-space: nowrap;\n\t\tbackground: #fff;\n\t\tpadding: 2px 6px;\n\t\tborder-radius: 3px;\n\t\tborder: 1px solid #e0e0e0;\n\t}\n\n\t\/* \u2500\u2500 Card posici\u00f3n arriba\/abajo \u2500\u2500 *\/\n\t.dtg-item--top .dtg-dot-wrap  { order: 2; margin-top: 8px; }\n\t.dtg-item--top .dtg-card      { order: 1; margin-bottom: 8px; }\n\t.dtg-item--bottom .dtg-dot-wrap { order: 1; margin-bottom: 8px; }\n\t.dtg-item--bottom .dtg-card   { order: 2; margin-top: 8px; }\n\n\t\/* \u2500\u2500 Card \u2500\u2500 *\/\n\t.dtg-card {\n\t\tbackground: #fff;\n\t\tborder-radius: 8px;\n\t\tpadding: 12px 14px;\n\t\twidth: 185px;\n\t\tbox-shadow: 0 2px 12px rgba(0,0,0,0.10);\n\t\tborder-top: 3px solid #e0e0e0;\n\t\ttransition: box-shadow 0.2s, transform 0.2s;\n\t\tbox-sizing: border-box;\n\t}\n\t.dtg-card:hover {\n\t\tbox-shadow: 0 6px 20px rgba(0,0,0,0.15);\n\t\ttransform: translateY(-3px);\n\t}\n\n\t\/* Colores borde top por tipo *\/\n\t.dtg-item--hito       .dtg-card { border-top-color: #2e7d32; }\n\t.dtg-item--resolucion .dtg-card { border-top-color: #1565c0; }\n\t.dtg-item--juridico   .dtg-card { border-top-color: #b71c1c; }\n\t.dtg-item--acta       .dtg-card { border-top-color: #6a1b9a; }\n\t.dtg-item--aviso      .dtg-card { border-top-color: #e65100; }\n\t.dtg-item--circular   .dtg-card { border-top-color: #e65100; }\n\t.dtg-item--informe    .dtg-card { border-top-color: #6a1b9a; }\n\n\t\/* Card bottom tiene borde abajo en vez de arriba *\/\n\t.dtg-card--bottom {\n\t\tborder-top: none;\n\t\tborder-bottom: 3px solid #e0e0e0;\n\t}\n\t.dtg-item--hito       .dtg-card--bottom { border-bottom-color: #2e7d32; }\n\t.dtg-item--resolucion .dtg-card--bottom { border-bottom-color: #1565c0; }\n\t.dtg-item--juridico   .dtg-card--bottom { border-bottom-color: #b71c1c; }\n\t.dtg-item--acta       .dtg-card--bottom { border-bottom-color: #6a1b9a; }\n\t.dtg-item--aviso      .dtg-card--bottom { border-bottom-color: #e65100; }\n\t.dtg-item--circular   .dtg-card--bottom { border-bottom-color: #e65100; }\n\t.dtg-item--informe    .dtg-card--bottom { border-bottom-color: #6a1b9a; }\n\n\t.dtg-tag {\n\t\tdisplay: inline-block;\n\t\tfont-size: 0.62rem;\n\t\tfont-weight: 700;\n\t\ttext-transform: uppercase;\n\t\tletter-spacing: 0.06em;\n\t\tpadding: 2px 7px;\n\t\tborder-radius: 20px;\n\t\tmargin-bottom: 6px;\n\t\tcolor: #fff;\n\t}\n\t.dtg-tag--hito       { background: #2e7d32; }\n\t.dtg-tag--resolucion { background: #1565c0; }\n\t.dtg-tag--juridico   { background: #b71c1c; }\n\t.dtg-tag--acta       { background: #6a1b9a; }\n\t.dtg-tag--aviso      { background: #e65100; }\n\t.dtg-tag--circular   { background: #e65100; }\n\t.dtg-tag--informe    { background: #6a1b9a; }\n\n\t.dtg-card__title {\n\t\tfont-size: 0.82rem;\n\t\tfont-weight: 700;\n\t\tcolor: #1a1a1a;\n\t\tmargin: 0 0 5px;\n\t\tline-height: 1.3;\n\t}\n\t.dtg-card__link {\n\t\tcolor: inherit;\n\t\ttext-decoration: none !important;\n\t\tborder: none !important;\n\t\tbox-shadow: none !important;\n\t\tdisplay: inline-flex;\n\t\talign-items: flex-start;\n\t\tgap: 4px;\n\t}\n\t.dtg-card__link:hover { color: #1565c0 !important; text-decoration: underline !important; }\n\t.dtg-card__link svg { flex-shrink: 0; margin-top: 2px; opacity: 0.6; }\n\t.dtg-card__desc {\n\t\tfont-size: 0.74rem;\n\t\tcolor: #555;\n\t\tline-height: 1.5;\n\t\tmargin: 0;\n\t}\n\n\t\/* \u2500\u2500 Responsive: vertical en m\u00f3vil \u2500\u2500 *\/\n\t@media (max-width: 700px) {\n\t\t.dtg-timeline {\n\t\t\tflex-direction: column;\n\t\t\tmin-width: unset;\n\t\t\tpadding: 20px 16px;\n\t\t\tgap: 0;\n\t\t\talign-items: flex-start;\n\t\t}\n\t\t.dtg-line {\n\t\t\ttop: 0;\n\t\t\tbottom: 0;\n\t\t\tleft: 28px;\n\t\t\tright: unset;\n\t\t\twidth: 3px;\n\t\t\theight: 100%;\n\t\t\ttransform: none;\n\t\t}\n\t\t.dtg-item {\n\t\t\tflex-direction: row;\n\t\t\twidth: 100%;\n\t\t\talign-items: flex-start;\n\t\t\tpadding: 12px 0;\n\t\t}\n\t\t.dtg-item--top .dtg-dot-wrap,\n\t\t.dtg-item--bottom .dtg-dot-wrap { order: 1; margin: 0 16px 0 0; flex-direction: column; align-items: center; width: 44px; }\n\t\t.dtg-item--top .dtg-card,\n\t\t.dtg-item--bottom .dtg-card { order: 2; width: 100%; margin: 0; border-top: 3px solid; border-bottom: none; }\n\t\t.dtg-item--hito       .dtg-card { border-top-color: #2e7d32 !important; }\n\t\t.dtg-item--resolucion .dtg-card { border-top-color: #1565c0 !important; }\n\t\t.dtg-item--juridico   .dtg-card { border-top-color: #b71c1c !important; }\n\t\t.dtg-item--circular   .dtg-card { border-top-color: #e65100 !important; }\n\t\t.dtg-item--informe    .dtg-card { border-top-color: #6a1b9a !important; }\n\t}\n\t<\/style>\n\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Colombia: Cronolog\u00eda del proceso de Licencia obligatoria La licencia obligatoria es una autorizaci\u00f3n otorgada por el gobierno para la explotaci\u00f3n de la materia patentada sin el consentimiento del titular, y tiene como finalidad garantizar determinados objetivos de pol\u00edtica p\u00fablica, como es el acceso a tratamientos. En Am\u00e9rica Latina, solo dos pa\u00edses han utilizado este mecanismo: [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_eb_attr":"","hide_page_title":"","footnotes":""},"class_list":["post-5034","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/pages\/5034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/comments?post=5034"}],"version-history":[{"count":13,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/pages\/5034\/revisions"}],"predecessor-version":[{"id":6686,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/pages\/5034\/revisions\/6686"}],"wp:attachment":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/media?parent=5034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}